GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sacituzumab tirumotecan
Related studies linked through entity extraction aliases.
Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-Based Combination Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan for Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sac-TMT for Active TNBC Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Status
- RECRUITING
- Phase
- PHASE3
Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2